Standout Papers
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)
- WITHIN‐SUBJECT COMPARISON OF REAL AND HYPOTHETICAL MONEY REWARDS IN DELAY DISCOUNTING (2002)
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction (2014)
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects (2011)
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness (2011)
- The Behavioral Economics of Substance Use Disorders: Reinforcement Pathologies and Their Repair (2014)
- Long-term follow-up of psilocybin-facilitated smoking cessation (2016)
- Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin (2015)
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences (2016)
- Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction (2015)
- Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function (2018)
- Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors (2017)
- Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up (2022)
- Potential Therapeutic Effects of Psilocybin (2017)
Immediate Impact
3 by Nobel laureates 10 from Science/Nature 166 standout
Citing Papers
Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors
2025 StandoutNature
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
2023 StandoutScience
Works of Matthew W. Johnson being referenced
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
2020 Standout
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
2016 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Matthew W. Johnson | 9595 | 4562 | 5245 | 169 | 14.4k | |
| Roland R. Griffiths | 12374 | 8786 | 6509 | 301 | 21.5k | |
| Harriet de Wit | 5719 | 12977 | 419 | 430 | 28.2k | |
| Wim van den Brink | 8851 | 5463 | 291 | 577 | 24.9k | |
| Caryn Lerman | 1209 | 1981 | 352 | 326 | 20.4k | |
| Alan C. Swann | 6176 | 3385 | 435 | 343 | 17.4k | |
| Jack E. Henningfield | 1192 | 2866 | 780 | 303 | 14.0k | |
| Valerie H. Curran | 2304 | 2676 | 684 | 138 | 8.8k | |
| Kathleen T. Brady | 9208 | 4095 | 132 | 469 | 22.9k | |
| Harrison G. Pope | 14049 | 2474 | 349 | 329 | 27.8k | |
| Murray E. Jarvik | 760 | 2765 | 247 | 212 | 9.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...